SGMO - Trade Savi - 360-degree view on crypto market

4503 SGMO

Sangamo inks $20M gene therapy deal with Astellas; shares rally

Sangamo Therapeutics enters a licensing agreement with Astellas Pharma for its STAC-BBB technology, receiving $20 million upfront and potential future earnings of up to $1.3 billion.

investing.com • 19/12/2024 - 11:38 AM

SGMO

Sangamo shares surge on Roche gene therapy withdrawal

Sangamo Therapeutics shares rose 36% after Roche halted its gene therapy program for hemophilia A, marking Sangamo's largest stock increase since October.

investing.com • 16/12/2024 - 20:02 PM

Greed and Fear Index

Note: The data is for reference only.

Extreme Greed

Sangamo inks $20M gene therapy deal with Astellas; shares rally

Sangamo shares surge on Roche gene therapy withdrawal

Greed and Fear Index

Currency